Urologist Dr. Jamin Brahmbhatt knows the complexities surrounding prostate-specific antigen testing with his patients. Here’s ...

Metabolic syndrome is associated with elevated levels of pain catastrophizing among patients with PsA and may impact disease activity.

Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...

Henry Butler is a prostate cancer survivor going on five years. He opens up about what recovery was like and how this journey ...

Former US president Joe Biden, 82, has been diagnosed with an “aggressive form” of prostate cancer, and it has spread to his ...

The combination of enzalutamide with androgen deprivation therapy (ADT) significantly increases the chance of five-year survival for men with metastatic hormone-sensitive prostate cancer, according to ...